Faculty Publications

Johnson WM, Fayad LE, Coiffier B, Smith MD, Rohatiner A, Hess G, Kaufman JL, Verhoef G, Offner F, Hua S, Patel H, Vandendries ER, Dang NH

SAFETY AND CLINICAL ACTIVITY OF THE ANTI-CD22 IMMUNOCONJUGATE INOTUZUMAB OZOGAMICIN (CMC-544) IN COMBINATION WITH RITUXIMAB IN RECURRENT/REFRACTORY FOLLICULAR LYMPHOMA OR DIFFUSE LARGE B-CELL LYMPHOMA

Haematologica-The Hematology Journal. 2009;94:165.

Abstract